T1	Participants 81 124	locally advanced non-small cell lung cancer
T2	Participants 404 465	Patients with stages II and IIIA/B non-small-cell lung cancer
T3	Participants 944 976	243 patients (pts) were enrolled
T4	Participants 1067 1116	85% of patients were ≤70 years; 75% had a KPS ≥90
